I agree that this site is using cookies. You can find further informations here.
X
Lichtlen, Peter
50  results:
Search for persons X
?
1

A Bispecific, Tetravalent Antibody Targeting Inflammatory a..:

Tietz, Julia ; Gunde, Tea ; Warmuth, Stefan...
JID Innovations.  4 (2024)  2 - p. 100258 , 2024
Link: https://doi.org/10.1016/..
 
?
2

An engineered T-cell engager with selectivity for high meso..:

Snell, Daniel ; Gunde, Tea ; Warmuth, Stefan...
OncoImmunology.  12 (2023)  1 - p. , 2023
Link: https://doi.org/10.1080/..
 
?
3

Lubiprostone for Pediatric Functional Constipation: Randomi..:

Benninga, Marc A. ; Hussain, Sunny Z. ; Sood, Manu R....
Clinical Gastroenterology and Hepatology.  20 (2022)  3 - p. 602-610.e5 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Correction to: Capsule and Sprinkle Formulations of Lubipro..:

Adams, Atoya ; Barish, Charles ; Chen, Angel...
Advances in Therapy.  38 (2021)  6 - p. 2953-2953 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Engineering of a trispecific tumor-targeted immunotherapy i..:

Warmuth, Stefan ; Gunde, Tea ; Snell, Daniel...
OncoImmunology.  10 (2021)  1 - p. , 2021
Link: https://doi.org/10.1080/..
 
?
6

Capsule and Sprinkle Formulations of Lubiprostone Are Not B..:

Adams, Atoya ; Barish, Charles ; Chen, Angel...
Advances in Therapy.  38 (2021)  6 - p. 2936-2952 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Effects of Lubiprostone, an Intestinal Secretagogue, on Ele..:

Rao, Satish S.C. ; Lichtlen, Peter ; Habibi, Sepideh
Journal of Clinical Gastroenterology.  55 (2020)  6 - p. 512-519 , 2020
Link: https://doi.org/10.1097/..
 
?
8

Su1643 - Efficacy and Safety of Lubiprostone in Children wi..:

Benninga, Marc A. ; Hussain, Sunny Z. ; Sood, Manu R....
Gastroenterology.  154 (2018)  6 - p. S-559-S-560 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Unmet Needs in Pediatric Functional Constipation:

Sood, Manu ; Lichtlen, Peter ; Perez, Maria Claudia
Clinical Pediatrics.  57 (2018)  13 - p. 1489-1495 , 2018
Link: https://doi.org/10.1177/..
 
?
10

The Cost Effectiveness of Lubiprostone in Chronic Idiopathi..:

Pennington, Becky ; Marriott, Emily-Ruth ; Lichtlen, Peter..
PharmacoEconomics - Open.  2 (2018)  3 - p. 241-253 , 2018
Link: https://doi.org/10.1007/..
 
?
11

Efficacy of Lubiprostone for the Treatment of Opioid-Induce..:

Webster, Lynn R ; Brewer, Randall P ; Lichtlen, Peter...
Pain Medicine.  19 (2017)  6 - p. 1195-1205 , 2017
Link: https://doi.org/10.1093/..
 
?
12

Su1585 Lubiprostone Responder Rates in Patients With Opioid..:

Losch-Beridon, Taryn ; Mareya, Shadreck M. ; Wang, Martin.
Gastroenterology.  150 (2016)  4 - p. S534 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Su1586 Lubiprostone Responder Rates in Patients With Chroni..:

Mareya, Shadreck M. ; Wang, Martin ; Losch-Beridon, Taryn.
Gastroenterology.  150 (2016)  4 - p. S534-S535 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Sa1394 Durability and Predictability of Response to Lubipro..:

Spierings, Egilius L. ; Losch-Beridon, Taryn R. ; Wang, Martin..
Gastroenterology.  148 (2015)  4 - p. S-313 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Mo1262 Effects of Baseline Abdominal Pain on Response to Lu..:

Chang, Lin ; Chey, William D. ; Drossman, Douglas A....
Gastroenterology.  148 (2015)  4 - p. S-653 , 2015
Link: https://doi.org/10.1016/..
 
1-15